See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
US Politics
Republican Party
Democratic Party
Tariffs
Donald Trump
Senate
US Economy
Tesla
Elon Musk
Stock Markets
White House
Social Media
Published • loading... • Updated

Mixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBC

Summary by MedPage Today
SAN ANTONIO -- Two trials of neoadjuvant immunotherapy for triple-negative breast cancer (TNBC) produced mixed efficacy signals. The NSABP B-59/GBG-96-GeparDouze

5 Articles

All
Left
Center
1
Right
MedPage TodayMedPage Today

Mixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBC

SAN ANTONIO -- Two trials of neoadjuvant immunotherapy for triple-negative breast cancer (TNBC) produced mixed efficacy signals. The NSABP B-59/GBG-96-GeparDouze

·New York, United States
Read Full Article
Stemwell Science NewsStemwell Science News

Targeting RTKs/nRTKs as Promising Therapeutic Strategies for the Treatment of Triple-Negative Breast Cancer: Evidence from Clinical Trials

Scientists summarize the various tyrosine kinase targeted therapeutics that have undergone scrutiny as potential therapeutic interventions for TNBC, dissecting the outcomes and revelations stemming from diverse clinical investigations. [Military Medical Research] Abstract

Read Full Article
MedscapeMedscape
Reposted by
DataemiaDataemia

Exploratory Analysis Identifies Biomarkers of Response in TNBC

New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to

·United States
Read Full Article
Medical XpressMedical Xpress

Clinical trial finds adding camrelizumab to neoadjuvant chemo beneficial in triple-negative breast cancer

The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or locally advanced triple-negative breast cancer, according to a study published online Dec. 13 in the Journal of the American Medical Association to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 13 in San Antonio.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Sunday, December 15, 2024.
Sources are mostly out of (0)

Similar News Topics

Breast Cancer

Breast Cancer

Medical

Medical

San Antonio, Texas

San Antonio, Texas

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal